Companies

Beam Therapeutics Inc. (BEAM) SEC filings

CIK 0001745999 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2022FY2021
Revenue (USD)139.7 M60.9 M
Net income (USD)-194.6 M-78.3 M
Diluted EPS (USD/shares)-0.81-4.13

Latest filings

FiledFormDescriptionPeriod
2026-10-16442026-10-15
2026-10-16144144
2026-10-15144144
2026-10-02442026-10-01
2026-09-25442026-09-24
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-13SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-0410-Q10-Q2026-06-30
2026-08-048-K8-K items 2.02,9.012026-08-04
2026-07-29442026-07-27
2026-07-27144144
2026-07-02442026-06-30
2026-07-01442026-06-29
2026-06-30144144
2026-06-29144144
2026-06-29442026-06-25
2026-06-22442026-06-17
2026-06-088-K8-K items 5.072026-06-03
2026-06-05442026-06-03
2026-06-05442026-06-03
2026-06-05442026-06-03
2026-06-05442026-06-03
2026-06-05442026-06-03
2026-06-05442026-06-03
2026-05-0710-Q10-Q2026-03-31

Forms on file (last 1,000): 4 208, 8-K 69, 144 43, SC 13G/A 27, 3 23, 10-Q 20, SCHEDULE 13G/A 17, SC 13G 13. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=BEAM (0.002 USD), /gw/filings/filings?ticker=BEAM&form=8-K, /gw/filings/facts?ticker=BEAM&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange